Загрузка...
Real-World Early Treatment with Room Temperature–Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7™ Post Hoc Analyses
Treating hemophilia A or B patients with inhibitors is particularly challenging, as they do not respond to replacement therapy with factor VIII or factor IX concentrates. A room temperature–stable formulation of recombinant activated factor VII (rFVIIa; NovoSeven®), which provides improved convenien...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Georg Thieme Verlag KG
2017-07-01
|
| Серии: | TH Open |
| Предметы: | |
| Online-ссылка: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1608943 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|